Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,748,363
+$1,732,232 QoQ
Shares Held
586,775
-13.7% QoQ
Ownership
0.352%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Derivatives in ALKS
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$11,743,206
PutShares
419,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Balyasny Asset Management L.P. holds $180,059,722 across 19 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
539,382 | $40,912,124 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
499,792 | $24,064,984 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
1,327,545 | $23,218,762 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
36,623 | $21,716,706 | |
| 5 | ALKS |
Alkermes plc.
This page
|
586,775 | $20,748,363 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
1,107,271 | $15,391,066 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
2,900,570 | $12,037,365 | |
| 8 | PRGO |
PERRIGO Co plc
|
804,856 | $8,644,153 |
All Filings in ALKS
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,748,363 | 586,775 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,743,206 | 419,700 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $19,016,131 | 679,633 | Shares | Sole | 2026-02-17 | |
| 2024-06-30 | $324,723 | 13,474 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,038,427 | 481,656 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $451,717 | 16,284 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $360,768 | 12,880 | Shares | Other | 2023-11-14 | |
| 2023-03-31 | $22,159,227 | 786,067 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $46,065,803 | 1,762,947 | Shares | Other | 2023-02-14 | |
| 2022-03-31 | $5,293,151 | 201,184 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $4,960,089 | 160,833 | Shares | Sole | 2021-12-01 | |
| 2021-03-31 | $7,285,200 | 390,000 | Call | Sole | 2021-05-17 | |
| 2021-03-31 | $9,930,755 | 531,625 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||